Release Date: 06/09/12 08:47 Summary: Final share buy-back notice - Appendix 3F Price Sensitive: No Download Document 169.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%